Which of the following drugs DO NOT cause hyperprolactinemia?
First, I need to recall which drugs are known to cause hyperprolactinemia. Common culprits include dopamine antagonists like antipsychotics (e.g., risperidone, haloperidol), metoclopramide, and certain antidepressants like SSRIs. Also, alpha-methyldopa and some antihypertensives can do that. On the other hand, drugs that inhibit dopamine release or have dopamine agonist effects might not cause it. For example, dopamine agonists like bromocriptine actually lower prolactin levels.
If the correct answer is a drug that doesn't interfere with dopamine pathways, then the distractors would be drugs that do. Let's assume the options include metoclopramide (A), risperidone (B), bromocriptine (C), and verapamil (D). The correct answer here would be C, bromocriptine, because it's a dopamine agonist and lowers prolactin. The others are either dopamine antagonists or have other mechanisms that increase prolactin.
Wait, but the user's correct answer is marked as [Letter]. [Answer Text], so maybe they intended a specific drug. Let me check again. If the correct answer is C. Bromocriptine, then the explanation should highlight that it's a dopamine agonist, thus decreasing prolactin. The other options would be drugs that block dopamine receptors, leading to increased prolactin. Also, some calcium channel blockers like verapamil can cause hyperprolactinemia by inhibiting dopamine release. So, if one of the options is a calcium channel blocker, that's a distractor. The key is to identify the drug that doesn't interfere with dopamine pathways in a way that increases prolactin.
**Core Concept**
Hyperprolactinemia results from dopamine receptor blockade or reduced dopamine synthesis, as dopamine inhibits prolactin secretion. Drugs causing this include dopamine antagonists (e.g., antipsychotics), metoclopramide, and certain antihypertensives. Dopamine agonists like bromocriptine lower prolactin.
**Why the Correct Answer is Right**
Bromocriptine is a dopamine agonist that directly stimulates D2 receptors in the pituitary gland, suppressing prolactin release. Unlike drugs that block dopamine receptors (e.g., risperidone) or reduce dopamine synthesis (e.g., metoclopramide), bromocriptine enhances dopamine activity, making it a treatment for hyperprolactinemia.
**Why Each Wrong Option is Incorrect**
**Option A (e.g., Risperidone):** Blocks dopamine D2 receptors, increasing prolactin.
**Option B (e.g., Metoclopramide):** Inhibits dopamine synthesis in the tuberoinfundibular pathway, causing hyperprolactinemia.
**Option D (e.g., Verapamil):** A calcium channel